FY 2025
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 31, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$58.75 B | $60.23 B | $64.97 B | $70.60 B | $75.60 B | $78.01 B |
|
Cost of Revenue Direct cost of goods/services. |
|
$36.26 B | $37.06 B | $39.39 B | $41.93 B | $44.23 B | $55.89 B |
Gross Profit Revenue minus cost of revenue. |
|
$22.49 B | $23.18 B | $25.58 B | $28.68 B | $31.37 B | $22.12 B |
|
Operating Expense
Costs to run business. 
|
|
$12.81 B | $14.12 B | $15.95 B | $18.13 B | $19.41 B | $10.05 B |
Operating Income Profit from operations. |
|
$9.68 B | $9.05 B | $9.63 B | $10.55 B | $11.97 B | $12.07 B |
|
Net Interest Income
Interest income minus expense.
|
|
-$1.53 B | -$1.74 B | -$1.94 B | -$2.06 B | -$2.25 B | -$2.32 B |
Non-Operating Income (ex-Int) Income outside core operations. |
|
-$1.72 B | -$1.27 B | -$17.00 M | -$37.00 M | -$115.00 M | -$88.00 M |
Total Other Income (Net) Net non-operating items. |
|
$155.00 M | -$473.00 M | -$1.92 B | -$2.02 B | -$2.13 B | -$2.20 B |
Income Before Tax Profit before taxes. |
|
$9.83 B | $8.58 B | $7.71 B | $8.52 B | $9.83 B | $9.87 B |
Income Tax Expense Taxes on income. |
|
$2.11 B | $1.75 B | $1.62 B | $1.87 B | $2.05 B | $2.02 B |
|
Net Income
Final profit.
|
|
$6.96 B | $5.64 B | $5.24 B | $5.76 B | $6.78 B | $6.84 B |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$21.51 | $19.44 | $19.24 | $22.27 | $28.62 | $29.96 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$21.16 | $19.15 | $18.96 | $22.00 | $28.38 | $29.87 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
323.32 M | 290.35 M | 272.40 M | 258.60 M | 230.71 M | 222.83 M |
Diluted Average Shares Outst. Shares including dilution. |
|
328.75 M | 294.67 M | 276.41 M | 261.81 M | 230.71 M | 222.83 M |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$11.40 B | $10.32 B | $9.64 B | $10.58 B | $12.08 B | $12.16 B |
EBITDA Earnings before interest, tax, D&A. |
|
$14.25 B | $13.29 B | $12.72 B | $13.90 B | $15.60 B | $15.84 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$2.85 B | $2.97 B | $3.08 B | $3.31 B | $3.52 B | $3.67 B |
| Company Report |
|
Sources
FY 2025
|
Sources
HCA Healthcare's Balance Sheet
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading balance sheet when needed... |
|
Sources
HCA Healthcare's Cash flow
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading cash flow statement when needed... |
|
Sources
HCA Healthcare's Profitability
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading profitability metrics when needed... |
|
Sources
HCA Healthcare's Ratios
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
|
Sources
